Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices
Trkulja, V. (2012). Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices. Medical Hypotheses, 78. (1), 157-161. doi: 10.1016/j.mehy.2011.10.016
Trkulja, Vladimir. "Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices." Medical Hypotheses, vol. 78, no. 1, 2012, pp. 157-161. https://doi.org/10.1016/j.mehy.2011.10.016
Trkulja, Vladimir. "Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices." Medical Hypotheses 78, no. 1 (2012): 157-161. https://doi.org/10.1016/j.mehy.2011.10.016
Trkulja, V. (2012) 'Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices', Medical Hypotheses, 78(1), pp. 157-161. doi: 10.1016/j.mehy.2011.10.016
Trkulja V. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices. Medical Hypotheses [Internet]. 2012 January [cited 2024 August 30];78(1):157-161. doi: 10.1016/j.mehy.2011.10.016
V. Trkulja, "Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices", Medical Hypotheses, vol. 78, no. 1, pp. 157-161, January 2012. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:400861. [Accessed: 30 August 2024]